Skip to main content
. 2021 Oct 13;13:758678. doi: 10.3389/fnagi.2021.758678

TABLE 1.

Clinical characteristics of patients, stratified by the presence of troponin dynamic changes.

Troponin dynamic changes
P
Yes (n = 66) No (n = 226)
Age, years (IQR) 81 (69–83) 69 (61–79) < 0.001
Male, n (%) 34 (51.5%) 158 (69.9%) 0.006
Vascular risk factors
  Hypertension, n (%) 52 (78.8%) 173 (76.5%) 0.70
  Diabetes mellitus, n (%) 15 (22.7%) 78 (34.5%) 0.071
  Hyperlipidemia, n (%) 24 (36.4%) 85 (37.6%) 0.85
  Current Smoking, n (%) 15 (22.7%) 53 (23.5%) 0.90
Comorbidities
  Atrial fibrillation, n (%) 36 (54.5%) 67 (29.6%) < 0.001
  Coronary artery disease, n (%) 12 (18.2%) 17 (7.5%) 0.011
  Previous stroke, n (%) 12 (18.2%) 24 (10.6%) 0.10
Treatment status
  OTT, min (mean ± SD) 157.8 ± 54.4 167.4 ± 56.7 0.24
  Ongoing antithrombotic therapy, n (%) 12 (18.2%) 32 (14.2%) 0.42
  Bridge therapy, n (%) 12 (18.2%) 30 (13.3%) 0.32
NIHSS score (IQR) 14 (9–18) 6 (4–12) < 0.001
Baseline SBP, mmHg (mean ± SD) 161.8 ± 25.3 159.4 ± 22.5 0.45
Baseline DBP, mmHg (mean ± SD) 88.3 ± 18.9 88.9 ± 15.8 0.79
Ejection fraction,% (IQR) 62 (58–67) 65 (61–68) 0.001
HT, n (%) 21 (31.8%) 30 (13.3%) < 0.001
Laboratory test
  Troponin elevation on admission, n (%) 26 (39.4%) 7 (3.1%) < 0.001
  Baseline blood glucose, mmol/L (IQR) 6.88 (5.88–9.16) 7.19 (6.09–9.35) 0.35
  Platelet, 109/L (IQR) 191 (158–226) 189 (165–227) 1.00
  INR (IQR) 1.06 (1.00–1.12) 1.03 (0.98–1.09) 0.011
  Creatinine, umol/L (IQR) 84 (65–105) 69 (59–83) < 0.001
  HbA1c,% (IQR) 5.70 (5.45–6.10) 5.91 (5.50–6.68) 0.065
  TC, mmol/L (IQR) 4.11 (3.61–4.96) 4.22 (3.69–5.12) 0.43
  LDL_C, mmol/L (IQR) 2.33 (1.87–3.17) 2.58 (2.11–3.34) 0.11
Stroke etiology 0.002
  Large artery atherosclerosis 18 (27.3) 69 (30.5)
  Cardioembolism 36 (54.5) 67 (29.6)
  Small vessel occlusion 5 (7.6) 54 (23.9)
  Other determined 1 (1.5) 8 (3.5)
  Undetermined 6 (9.1) 28 (12.4)

DBP, diastolic blood pressure; HT, hemorrhagic transformation; INR, international normalized ratio; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol; NIHSS, National Institutes of Health Stroke Scale; OTT, onset-to-treatment time; SBP, systolic blood pressure; SD, standard deviation; TC, total cholesterol. The bold values represent significant results in univariate analysis (P < 0.05).